
Anna Pagonakis
Examiner (ID: 6985)
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1614, 4173, 1609, 1628, OPET |
| Total Applications | 1238 |
| Issued Applications | 444 |
| Pending Applications | 73 |
| Abandoned Applications | 723 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5515597
[patent_doc_number] => 20090215904
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'COLCHICINE COMPOSITIONS AND METHODS'
[patent_app_type] => utility
[patent_app_number] => 12/465210
[patent_app_country] => US
[patent_app_date] => 2009-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24204
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0215/20090215904.pdf
[firstpage_image] =>[orig_patent_app_number] => 12465210
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/465210 | COLCHICINE COMPOSITIONS AND METHODS | May 12, 2009 | Abandoned |
Array
(
[id] => 5484928
[patent_doc_number] => 20090274693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-05
[patent_title] => 'Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor'
[patent_app_type] => utility
[patent_app_number] => 12/435473
[patent_app_country] => US
[patent_app_date] => 2009-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9217
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20090274693.pdf
[firstpage_image] =>[orig_patent_app_number] => 12435473
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/435473 | Method of Treating Cancer using a cMet and AXL Inhibitor and an ErbB Inhibitor | May 4, 2009 | Abandoned |
Array
(
[id] => 5315514
[patent_doc_number] => 20090280112
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS'
[patent_app_type] => utility
[patent_app_number] => 12/434071
[patent_app_country] => US
[patent_app_date] => 2009-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14026
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20090280112.pdf
[firstpage_image] =>[orig_patent_app_number] => 12434071
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/434071 | INHIBITORY EFFECTS OF NORDIHYDROGUAIARETIC ACID (NDGA) ON THE IGF-1 RECEPTOR AND ANDROGEN DEPENDENT GROWTH OF LAPC-4 PROSTATE CANCER CELLS | Apr 30, 2009 | Abandoned |
Array
(
[id] => 5392321
[patent_doc_number] => 20090209634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-20
[patent_title] => 'USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS'
[patent_app_type] => utility
[patent_app_number] => 12/431141
[patent_app_country] => US
[patent_app_date] => 2009-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20035
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0209/20090209634.pdf
[firstpage_image] =>[orig_patent_app_number] => 12431141
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/431141 | USE OF BENZO-FUSED HETEROCYCLE SULFAMIDE DERIVATIVES FOR DISEASE MODIFICATION / EPILEPTOGENESIS | Apr 27, 2009 | Abandoned |
Array
(
[id] => 6548797
[patent_doc_number] => 20100222401
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY'
[patent_app_type] => utility
[patent_app_number] => 12/667168
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 38581
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0222/20100222401.pdf
[firstpage_image] =>[orig_patent_app_number] => 12667168
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/667168 | COMPOSITIONS AND METHODS FOR TREATING PATHOLOGIC ANGIOGENESIS AND VASCULAR PERMEABILITY | Apr 15, 2009 | Abandoned |
Array
(
[id] => 5943538
[patent_doc_number] => 20110104158
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-05
[patent_title] => 'DEUTERIUM BEARING ANALOGS OF ANASTROZOLE AS AROMATASE INHIBITORS FOR THE TREATMENT OF BREAST CANCER'
[patent_app_type] => utility
[patent_app_number] => 12/937935
[patent_app_country] => US
[patent_app_date] => 2009-04-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7211
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20110104158.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937935
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937935 | DEUTERIUM BEARING ANALOGS OF ANASTROZOLE AS AROMATASE INHIBITORS FOR THE TREATMENT OF BREAST CANCER | Apr 14, 2009 | Abandoned |
Array
(
[id] => 9608256
[patent_doc_number] => 08785423
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-07-22
[patent_title] => 'Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases'
[patent_app_type] => utility
[patent_app_number] => 12/937900
[patent_app_country] => US
[patent_app_date] => 2009-04-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 8725
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12937900
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937900 | Compositions and methods of inducing endoplasmic reticulum stress response for the treatment of cell proliferative diseases | Apr 13, 2009 | Issued |
Array
(
[id] => 5527836
[patent_doc_number] => 20090197913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'SYNERGISTIC MODULATION OF FLT3 KINASE USING A FLT3 INHIBITOR AND A FARNESYL TRANSFERASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/421778
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 70427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421778 | Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor | Apr 9, 2009 | Issued |
Array
(
[id] => 5527836
[patent_doc_number] => 20090197913
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-06
[patent_title] => 'SYNERGISTIC MODULATION OF FLT3 KINASE USING A FLT3 INHIBITOR AND A FARNESYL TRANSFERASE INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 12/421778
[patent_app_country] => US
[patent_app_date] => 2009-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 70427
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0197/20090197913.pdf
[firstpage_image] =>[orig_patent_app_number] => 12421778
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/421778 | Synergistic modulation of FLT3 kinase using a FLT3 inhibitor and a farnesyl transferase inhibitor | Apr 9, 2009 | Issued |
Array
(
[id] => 5558820
[patent_doc_number] => 20090270397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-29
[patent_title] => 'Methods and compositions for the treatment of cancers, such as melanomas and gliomas'
[patent_app_type] => utility
[patent_app_number] => 12/384777
[patent_app_country] => US
[patent_app_date] => 2009-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15952
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0270/20090270397.pdf
[firstpage_image] =>[orig_patent_app_number] => 12384777
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/384777 | Methods and compositions for the treatment of cancers, such as melanomas and gliomas | Apr 7, 2009 | Abandoned |
Array
(
[id] => 5458786
[patent_doc_number] => 20090258938
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Administration of 6\'-ethyl lepimectin, 6\' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans'
[patent_app_type] => utility
[patent_app_number] => 12/382888
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2892
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258938.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382888
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382888 | Administration of 6'-ethyl lepimectin, 6' -methyl lepimectin or derivatives thereof for treating dermatological disorders in humans | Mar 25, 2009 | Abandoned |
Array
(
[id] => 5496488
[patent_doc_number] => 20090264516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-22
[patent_title] => 'Milbemycin compounds and treatment of dermatological disorders in humans therewith'
[patent_app_type] => utility
[patent_app_number] => 12/382892
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3147
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20090264516.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382892
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382892 | Milbemycin compounds and treatment of dermatological disorders in humans therewith | Mar 25, 2009 | Abandoned |
Array
(
[id] => 5316577
[patent_doc_number] => 20090281175
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-12
[patent_title] => 'Avermectin compounds and treatment of dermatological disorders in humans therewith'
[patent_app_type] => utility
[patent_app_number] => 12/382890
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2989
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0281/20090281175.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382890
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382890 | Avermectin compounds and treatment of dermatological disorders in humans therewith | Mar 25, 2009 | Abandoned |
Array
(
[id] => 4451323
[patent_doc_number] => 07964647
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-06-21
[patent_title] => 'Colchicine compositions and methods'
[patent_app_type] => utility
[patent_app_number] => 12/407980
[patent_app_country] => US
[patent_app_date] => 2009-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 24214
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/964/07964647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12407980
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/407980 | Colchicine compositions and methods | Mar 19, 2009 | Issued |
Array
(
[id] => 5374812
[patent_doc_number] => 20090312373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-17
[patent_title] => 'METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS'
[patent_app_type] => utility
[patent_app_number] => 12/401099
[patent_app_country] => US
[patent_app_date] => 2009-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 20126
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 34
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20090312373.pdf
[firstpage_image] =>[orig_patent_app_number] => 12401099
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/401099 | METHODS FOR THE TREATMENT OF CANCER USING PIPERLONGUMINE AND PIPERLONGUMINE ANALOGS | Mar 9, 2009 | Abandoned |
Array
(
[id] => 5436343
[patent_doc_number] => 20090170930
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS'
[patent_app_type] => utility
[patent_app_number] => 12/400756
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 3421
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20090170930.pdf
[firstpage_image] =>[orig_patent_app_number] => 12400756
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/400756 | METHODS FOR DIRECTING DIFFERENTIATION OF CLONOGENIC NEURAL STEM CELLS WITH COUMARINS | Mar 8, 2009 | Abandoned |
Array
(
[id] => 6159513
[patent_doc_number] => 20110158983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-06-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES'
[patent_app_type] => utility
[patent_app_number] => 12/921145
[patent_app_country] => US
[patent_app_date] => 2009-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 57903
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0158/20110158983.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921145
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921145 | COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES | Mar 4, 2009 | Abandoned |
Array
(
[id] => 6228822
[patent_doc_number] => 20100183560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Angiogenesis-modulating compositions and uses'
[patent_app_type] => utility
[patent_app_number] => 12/380583
[patent_app_country] => US
[patent_app_date] => 2009-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 48881
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12380583
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/380583 | Angiogenesis-modulating compositions and uses | Feb 26, 2009 | Abandoned |
Array
(
[id] => 5369020
[patent_doc_number] => 20090306579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-10
[patent_title] => 'DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS'
[patent_app_type] => utility
[patent_app_number] => 12/391836
[patent_app_country] => US
[patent_app_date] => 2009-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 9304
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20090306579.pdf
[firstpage_image] =>[orig_patent_app_number] => 12391836
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/391836 | DELIVERY OF CORTICOSTEROIDS THROUGH IONTOPHORESIS | Feb 23, 2009 | Abandoned |
Array
(
[id] => 6531788
[patent_doc_number] => 20100221307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-02
[patent_title] => 'ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 12/733795
[patent_app_country] => US
[patent_app_date] => 2009-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10377
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0221/20100221307.pdf
[firstpage_image] =>[orig_patent_app_number] => 12733795
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/733795 | ANTIVIRAL AGENTS, ANTIVIRAL FIBERS AND ANTIVIRAL FIBER STRUCTURES | Feb 19, 2009 | Abandoned |